Channels
- Practice Area
- Administrative Law
- Admiralty & Maritime Law
- Advertising Law
- Alternative Dispute Resolution
- AmLaw 200 Blogs
- Antitrust Law
- Bankruptcy
- Civil Rights & Privacy Law
- Consumer Law
- Corporate & Commercial Litigation
- Criminal Law
- Divorce & Family Law
- Education Law
- Election Law & Political Commentary
- Electronic Discovery
- Employment & Labor Law
- Environmental Law
- General Counsel Blogs
- Immigration Law
- Insurance Law
- Intellectual Property Law
- International Law
- Judiciary Law
- Media, Entertainment & Sports Law
- Law Firm Management & Legal Marketing
- Personal Injury & Medical Law
- Probate & Estate Planning
- Real Estate & Construction Law
- Tax & Financial Law
- Technology
- Whistleblower Law
- Workers' Compensation
- Law School
cipla
Europe Seizure of generic drugs: Lilly settles with Indian generics
We have blogged about the seizure of generic drugs, here.I recently saw an article on the Financial Times.com website which says that Eli Lilly is now settling the matter of seizure of generic drugs with the Indian generic manufacturers.After the initial seizures at Schipol and other European...
India: Supreme Court dismisses Bayer' petition in patent linkage matter
Spicy IP, yesterday, broke the news regarding dismissal of Bayer's Petition at the Supreme Court. The matter was earlier adjourned in August.We now have some more information, courtesy again - Pratibha Siva (Lawyers Collective).The Supreme Court of India dismissed the appeal filed by Bayer...
India: new decisions from the Patent Office
I have put a small summary of recent decisions, here.Meanwhile, if any of you have the decisions that I asked for earlier, please feel free to email me.
INDIA: Sorafenib Litigation --> Bayer v. Cipla [update]
Spicy IP has done an excellent summary on the recent moves in the Bayer v. Cipla (Sorafenib) litigation.I recommend reading their post, here.Our old posts on Sorafenib, here.
India: Cipla v. Richter Gedeon
Cipla and Richter Gedeon were contesting the latter's patent IN206098 (for contraceptive drug Levonorgestrel) at the Mumbai patent office in a post grant opposition proceeding. This patent comes from WO03045397. This WO document was also the subject of connected Indian patent revocation (IN202297),...
